1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Schibli, D.J. Hunter, H.N. Aseyev, V. Starner, T.D. Wiencek, J.M. McCray Jr., P.B. Tack, B.F. Vogel, H.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 277 8279 8289 10.1074/jbc.M108830200 11741980 The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. 2002 10.2210/pdb1kj6/pdb pdb_00001kj6 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 5174.266 Beta-defensin 3 1 man polymer BD-3, hBD-3 no no GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-03-20 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model Solution Structure of Human beta-Defensin 1 RCSB Y RCSB 2001-12-04 REL This structure was determined using standard 2D homonuclear techniques. structures with the lowest energy 100 20 2D NOESY 2D TOCSY 2D COSY 2D NOESY 4.00 ambient 298 K Distance geometry, Simulated Annealing, Molecular Dynamics 1 closest to the average 0.36 mM HBD3 90% H2O/10% D2O 0.36 mM HBD3 100% D2O Bruker collection XwinNMR 2.6 Delaglio, G., Grzejiek, S., Vuister, G., Zhu, G., Pfeifer, J., Bax, A. processing NMRPipe 1.8 Johnson, B.A., Blevins, R.A. data analysis NMRView 4.1.3 A.T.Brunger, P.D.Adams, G.M.Clore, W.L.Delano, P.Gros, R.W.Grosse-Kunstleve, J.-S.Jiang, J.Kuszewski, M.Nilges, N.S.Pannu, R.J.Read, L.M.Rice, T.Simonson, G.L.Warren refinement CNS 1.0 J.Linge, S.O'Donoghue, M.Nilges refinement ARIA 1.0 500 Bruker AVANCE 800 Varian INOVA GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A ILE 3 n 3 ILE 3 A ASN 4 n 4 ASN 4 A THR 5 n 5 THR 5 A LEU 6 n 6 LEU 6 A GLN 7 n 7 GLN 7 A LYS 8 n 8 LYS 8 A TYR 9 n 9 TYR 9 A TYR 10 n 10 TYR 10 A CYS 11 n 11 CYS 11 A ARG 12 n 12 ARG 12 A VAL 13 n 13 VAL 13 A ARG 14 n 14 ARG 14 A GLY 15 n 15 GLY 15 A GLY 16 n 16 GLY 16 A ARG 17 n 17 ARG 17 A CYS 18 n 18 CYS 18 A ALA 19 n 19 ALA 19 A VAL 20 n 20 VAL 20 A LEU 21 n 21 LEU 21 A SER 22 n 22 SER 22 A CYS 23 n 23 CYS 23 A LEU 24 n 24 LEU 24 A PRO 25 n 25 PRO 25 A LYS 26 n 26 LYS 26 A GLU 27 n 27 GLU 27 A GLU 28 n 28 GLU 28 A GLN 29 n 29 GLN 29 A ILE 30 n 30 ILE 30 A GLY 31 n 31 GLY 31 A LYS 32 n 32 LYS 32 A CYS 33 n 33 CYS 33 A SER 34 n 34 SER 34 A THR 35 n 35 THR 35 A ARG 36 n 36 ARG 36 A GLY 37 n 37 GLY 37 A ARG 38 n 38 ARG 38 A LYS 39 n 39 LYS 39 A CYS 40 n 40 CYS 40 A CYS 41 n 41 CYS 41 A ARG 42 n 42 ARG 42 A ARG 43 n 43 ARG 43 A LYS 44 n 44 LYS 44 A LYS 45 n 45 LYS 45 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ARG 17 A N ARG 17 A O CYS 41 A O CYS 41 A O CYS 40 A O CYS 40 A N GLY 31 A N GLY 31 1 A LEU 6 -161.80 42.76 1 A TYR 9 -154.78 21.40 1 A ARG 14 -174.78 36.19 1 A LEU 21 -130.62 -68.27 1 A SER 34 -151.78 -97.31 1 A THR 35 -171.59 -27.51 1 A ARG 36 -166.73 108.56 2 A ASN 4 -106.50 46.28 2 A LEU 6 -109.67 43.46 2 A TYR 9 -155.92 28.32 2 A ARG 14 -168.50 52.86 2 A LEU 21 -114.64 -80.18 2 A CYS 23 -48.45 162.63 2 A PRO 25 -71.21 24.48 2 A LYS 26 -146.51 20.99 2 A ARG 43 -39.20 131.19 3 A TYR 9 -156.49 36.17 3 A ARG 14 -152.08 26.73 3 A LEU 21 -120.75 -70.52 3 A CYS 23 -59.60 174.74 4 A LEU 6 -92.76 49.16 4 A TYR 9 -155.65 30.26 4 A ARG 14 -168.15 25.67 4 A LEU 21 -132.71 -60.90 4 A CYS 23 -57.66 173.49 4 A CYS 33 -51.48 -83.02 4 A ARG 36 -48.73 109.52 5 A THR 5 -137.69 -159.71 5 A TYR 9 -155.62 17.74 5 A ARG 14 -152.79 61.78 5 A LEU 21 -129.88 -80.67 5 A CYS 23 -55.22 172.65 5 A PRO 25 -74.42 27.53 5 A LYS 26 -146.86 11.05 5 A ARG 36 -72.78 -79.97 6 A TYR 9 -154.91 25.37 6 A ARG 14 -165.22 -72.50 6 A LEU 21 -131.93 -69.56 6 A CYS 23 -54.70 171.37 6 A PRO 25 -71.98 27.37 6 A LYS 26 -146.83 15.00 6 A SER 34 -106.70 -77.60 6 A THR 35 -169.43 -33.38 6 A ARG 36 -166.90 -10.87 7 A ASN 4 -92.77 -61.76 7 A THR 5 -139.17 -80.44 7 A LEU 6 -168.86 43.33 7 A TYR 9 -154.56 28.06 7 A ARG 14 -156.64 46.79 7 A LEU 21 -125.37 -66.68 7 A CYS 23 -48.75 152.09 7 A ARG 36 -107.31 -74.42 8 A ASN 4 -143.75 -70.48 8 A THR 5 -101.28 -167.13 8 A TYR 9 -153.49 16.61 8 A ARG 14 -175.09 46.69 8 A LEU 21 -129.23 -63.94 8 A CYS 23 -57.29 172.19 8 A SER 34 -139.53 -98.18 8 A THR 35 -136.16 -43.07 8 A ARG 36 -161.93 -12.08 9 A LEU 6 -161.71 41.21 9 A TYR 9 -154.33 13.28 9 A ARG 14 -144.35 -71.33 9 A LEU 21 -135.13 -49.72 9 A CYS 23 -58.96 176.39 9 A PRO 25 -75.61 27.07 10 A LEU 6 -102.84 41.17 10 A TYR 9 -155.14 29.86 10 A ARG 14 -169.43 33.66 10 A LEU 21 -121.10 -80.34 10 A LYS 44 -119.65 66.66 11 A ASN 4 -109.53 51.61 11 A LEU 6 -88.94 38.19 11 A TYR 9 -150.65 34.67 11 A ARG 14 -164.35 30.97 11 A LEU 21 -130.98 -62.67 11 A CYS 23 -55.32 171.45 11 A PRO 25 -71.34 25.28 11 A SER 34 -111.59 -163.84 12 A ASN 4 -95.06 -73.59 12 A TYR 9 -152.73 21.42 12 A ARG 14 -160.98 -63.84 12 A LEU 21 -120.77 -78.23 12 A CYS 23 -58.21 174.82 13 A TYR 9 -157.19 29.65 13 A ARG 14 -149.24 -67.68 13 A CYS 23 -57.41 172.57 13 A SER 34 -138.86 -96.22 13 A THR 35 -137.88 -63.42 13 A ARG 36 -150.03 -20.76 14 A TYR 9 -154.89 25.31 14 A ARG 14 -166.88 42.12 14 A LEU 21 -134.53 -40.36 14 A ARG 36 -171.60 145.34 15 A THR 5 -141.27 -88.67 15 A LEU 6 -172.23 30.99 15 A GLN 7 -65.40 0.55 15 A TYR 9 -154.75 22.48 15 A ARG 14 -156.03 -60.11 15 A LEU 21 -129.27 -86.81 16 A TYR 9 -155.21 15.09 16 A ARG 14 -156.40 12.77 16 A LEU 21 -127.13 -60.54 16 A PRO 25 -70.57 22.47 16 A LYS 26 -144.01 19.80 16 A ARG 36 -167.28 103.26 17 A LEU 6 -97.00 36.44 17 A TYR 9 -155.20 17.38 17 A ARG 14 -144.97 26.02 17 A SER 34 -163.84 -83.86 17 A THR 35 -133.12 -159.27 18 A LEU 6 -107.85 40.71 18 A TYR 9 -156.19 32.93 18 A ARG 14 -144.65 19.81 18 A LEU 21 -130.76 -51.94 18 A PRO 25 -73.56 23.66 18 A LYS 26 -146.91 22.26 18 A SER 34 -138.28 -87.64 18 A THR 35 -108.15 -160.94 19 A ASN 4 -131.84 -65.31 19 A TYR 9 -155.48 21.36 19 A ARG 14 -161.81 -62.02 19 A LEU 21 -128.46 -62.52 19 A CYS 23 -56.41 173.70 19 A SER 34 -124.05 -169.95 19 A THR 35 -64.68 -75.87 20 A ILE 2 -66.98 91.74 20 A ASN 4 -66.39 -170.94 20 A LEU 6 -93.85 58.24 20 A TYR 9 -154.86 31.64 20 A ARG 14 -172.57 33.11 20 A LEU 21 -126.42 -77.94 20 A CYS 23 -56.18 170.33 20 A PRO 25 -71.25 23.57 20 A LYS 26 -147.13 16.29 20 A ARG 36 -165.25 107.80 Solution Structure of Human beta-Defensin 3 1 N N A TYR 9 A TYR 9 HELX_P A GLY 15 A GLY 15 1 1 7 disulf 2.028 A CYS 11 A SG CYS 11 1_555 A CYS 40 A SG CYS 40 1_555 disulf 2.031 A CYS 18 A SG CYS 18 1_555 A CYS 33 A SG CYS 33 1_555 disulf 2.028 A CYS 23 A SG CYS 23 1_555 A CYS 41 A SG CYS 41 1_555 ANTIBIOTIC defensin, antimicrobial protein, human beta-defensin 3, beta-defensin, HBD3, ANTIBIOTIC D103A_HUMAN UNP 1 23 P81534 GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK 23 67 1KJ6 1 45 P81534 A 1 1 45 3 anti-parallel anti-parallel A ARG 17 A ARG 17 A ALA 19 A ALA 19 A LYS 39 A LYS 39 A ARG 43 A ARG 43 A GLU 27 A GLU 27 A GLY 31 A GLY 31